VYOME HOLDINGS, INC. Amortization of Intangible Assets
VYOME HOLDINGS, INC. (HIND) reported Amortization of Intangible Assets of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2025-04-04
- VYOME HOLDINGS, INC. amortization of intangible assets for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. amortization of intangible assets for the quarter ending 2023-09-30 was $11.00K, a 97.80% decline year-over-year.
- VYOME HOLDINGS, INC. amortization of intangible assets for the quarter ending 2023-06-30 was $11.00K, a 97.80% decline year-over-year.
- VYOME HOLDINGS, INC. amortization of intangible assets for the quarter ending 2023-03-31 was $11.00K, a 97.59% decline year-over-year.
- VYOME HOLDINGS, INC. amortization of intangible assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- VYOME HOLDINGS, INC. amortization of intangible assets for fiscal 2023 was $33.00K, a 98.19% decline from fiscal 2022.
- VYOME HOLDINGS, INC. amortization of intangible assets for fiscal 2022 was $1.82M, a 4.83% increase from fiscal 2021.
- VYOME HOLDINGS, INC. amortization of intangible assets for fiscal 2021 was $1.74M, a 5.27% increase from fiscal 2020.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-04-04 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $11.00K derived: sum of 2 quarters · filed 2025-04-04 | $22.00K derived: sum of 3 quarters · filed 2025-04-04 | $33.00K 10-K · filed 2025-04-04 |
| 2023-09-30 | $11.00K 10-Q · filed 2023-11-09 | $22.00K derived: sum of 2 quarters · filed 2023-11-09 | $33.00K 10-Q · filed 2024-11-14 | $489.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-06-30 | $11.00K 10-Q · filed 2023-08-07 | $22.00K 10-Q · filed 2024-08-14 | $478.00K derived: sum of 3 quarters · filed 2024-05-15 | $978.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-03-31 | $11.00K 10-Q · filed 2024-05-15 | $467.00K derived: sum of 2 quarters · filed 2024-05-15 | $967.00K derived: sum of 3 quarters · filed 2024-05-15 | $1.47M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $456.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $956.00K derived: sum of 2 quarters · filed 2024-04-01 | $1.46M derived: sum of 3 quarters · filed 2024-04-01 | $1.82M 10-K · filed 2024-04-01 |
| 2022-09-30 | $500.00K 10-Q · filed 2023-11-09 | $1.00M derived: sum of 2 quarters · filed 2023-11-09 | $1.37M 10-Q · filed 2023-11-09 | $1.91M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $500.00K 10-Q · filed 2023-08-07 | $911.00K 10-Q · filed 2023-08-07 | $1.41M derived: sum of 3 quarters · filed 2023-08-07 | $1.91M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $456.00K 10-Q · filed 2023-05-15 | $911.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.41M derived: sum of 3 quarters · filed 2023-05-15 | $1.81M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $955.00K derived: sum of 2 quarters · filed 2023-04-17 | $1.35M derived: sum of 3 quarters · filed 2023-04-17 | $1.74M 10-K · filed 2023-04-17 |
| 2021-09-30 | $500.00K 10-Q · filed 2022-11-14 | $900.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.28M 10-Q · filed 2022-11-14 | $1.71M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $400.00K 10-Q · filed 2022-08-19 | $828.00K 10-Q · filed 2022-08-19 | $1.21M derived: sum of 3 quarters · filed 2022-08-19 | $1.71M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-03-31 | $411.00K 10-Q · filed 2022-05-23 | $814.00K derived: sum of 2 quarters · filed 2022-05-23 | $1.31M derived: sum of 3 quarters · filed 2022-05-23 | $1.71M derived: sum of 4 quarters · filed 2022-05-23 |
| 2020-12-31 | $403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $903.00K derived: sum of 2 quarters · filed 2022-04-08 | $1.30M derived: sum of 3 quarters · filed 2022-04-08 | $1.65M 10-K · filed 2022-04-08 |
| 2020-09-30 | $500.00K 10-Q · filed 2021-11-12 | $900.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.25M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $400.00K 10-Q · filed 2021-08-16 | $833.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |